News

Press releases and news from regional sources, click on original post link to read the full article and see what’s trending. Click Here to Publish/Feature Your Company or Product News with Biotech Networks

News

Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases–according to Nature study

November 12, 2025 SDBN Comments Off on Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases–according to Nature study

Study shows that rare variants captured by Illumina WGS with DRAGEN™ variant calling explain most of the “missing heritability” in complex human diseases and traits, including those related to blood pressure and cholesterol Results demonstrate […]


ADVERTISEMENT — Advertise With Biotech Networks
News

P2 Science and Algenesis Partner to Develop Algae-Derived Chemicals and 100% Biobased, Biodegradable Polyurethanes

November 12, 2025 SDBN Comments Off on P2 Science and Algenesis Partner to Develop Algae-Derived Chemicals and 100% Biobased, Biodegradable Polyurethanes

Innovative collaboration combines P2’s proprietary green chemistry PIOz™ process with Algenesis’ Bio-Iso™ innovation WOODBRIDGE, Conn. and SAN DIEGO, Nov. 12, 2025 /PRNewswire/ — P2 Science, Inc., a pioneer in green chemistry and sustainable materials, and […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Reviva to Present Anti-Inflammatory Impacts of Brilaroxazine in Schizophrenia from the RECOVER 12-month Open Label Extension Trial at Neuroscience 2025

November 12, 2025 SDBN Comments Off on Reviva to Present Anti-Inflammatory Impacts of Brilaroxazine in Schizophrenia from the RECOVER 12-month Open Label Extension Trial at Neuroscience 2025

CUPERTINO, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Capricor Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

November 10, 2025 SDBN Comments Off on Capricor Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced its financial results for the third […]

News

Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-1070770 in Adults with Major Depressive Disorder

November 10, 2025 SDBN Comments Off on Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-1070770 in Adults with Major Depressive Disorder

SAN DIEGO, Nov. 10, 2025 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Phase 2 study evaluating the efficacy, safety and tolerability of investigational compound NBI-1070770 in adults with major depressive disorder […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks

November 10, 2025 SDBN Comments Off on Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks

Following global commercial launch in September, Illumina Protein Prep’s “out of the box” solution drives extraordinary accessibility to proteomics for researchers, with over 40,000 samples processed Sydney Mass Spectrometry is the first facility in the […]

No Picture
News

Anaptys Announces Phase 2 Trial of Rosnilimab Did Not Meet Primary or Secondary Endpoints at Week 12 in Moderate-to-Severe Ulcerative Colitis

November 10, 2025 SDBN Comments Off on Anaptys Announces Phase 2 Trial of Rosnilimab Did Not Meet Primary or Secondary Endpoints at Week 12 in Moderate-to-Severe Ulcerative Colitis

SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that investigational rosnilimab was safe and well tolerated but did not […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Calidi Biotherapeutics Presents New Data on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting and Holds Its First Investor Day at SITC

November 10, 2025 SDBN Comments Off on Calidi Biotherapeutics Presents New Data on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting and Holds Its First Investor Day at SITC

SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of systemically delivered, targeted genetic medicines, presented new data on […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Iambic Raises Over $100 Million in an Oversubscribed Round to Advance Its Portfolio of AI-Discovered Therapeutics and Leading Platform Technologies

November 10, 2025 SDBN Comments Off on Iambic Raises Over $100 Million in an Oversubscribed Round to Advance Its Portfolio of AI-Discovered Therapeutics and Leading Platform Technologies

SAN DIEGO–(BUSINESS WIRE)–Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, today announced raising over $100 million in an oversubscribed financing round with balanced support from […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Primrose Bio Launches Prima RNApols™ ExTend Cap AU, a Next-Gen RNA Polymerase for Self-Amplifying mRNA

November 10, 2025 SDBN Comments Off on Primrose Bio Launches Prima RNApols™ ExTend Cap AU, a Next-Gen RNA Polymerase for Self-Amplifying mRNA

Maximize capping efficiency and minimize double-stranded RNA (“dsRNA”) in the manufacturing of self-amplifying mRNA SAN DIEGO, Nov. 10, 2025 /PRNewswire/ — Primrose Bio, Inc. (“Primrose”), a company with proprietary therapeutic manufacturing technologies, today announced the […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

??Onchilles Pharma Publishes Landmark ELANE Pathway Study and Advances N17350 Toward the Clinic With New Financing and Leading Clinical Advisor

November 7, 2025 SDBN Comments Off on ??Onchilles Pharma Publishes Landmark ELANE Pathway Study and Advances N17350 Toward the Clinic With New Financing and Leading Clinical Advisor

SAN DIEGO–(BUSINESS WIRE)– #ELANE–Onchilles Pharma Publishes Landmark ELANE Pathway Study and Advances N17350 Toward the Clinic With New Financing and Leading Clinical Advisor Click here to view original post Click Here to Publish/Feature Your Company […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025

November 7, 2025 SDBN Comments Off on Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025

SAN DIEGO, Nov. 7, 2025 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial […]

News

FDA Approved DARZALEX Faspro® for Adult Patients with High-Risk Smoldering Multiple Myeloma

November 7, 2025 SDBN Comments Off on FDA Approved DARZALEX Faspro® for Adult Patients with High-Risk Smoldering Multiple Myeloma

DARZALEX Faspro® is co-formulated with Halozyme’s ENHANZE® drug delivery technology SAN DIEGO, Nov. 7, 2025 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that Johnson & Johnson received U.S. Food and Drug Administration […]